EULAR: RA Effects Persist Despite Treatment - MedPage Today

MedIndia

EULAR: RA Effects Persist Despite Treatment MedPage Today Explain to interested patients that pain often persists with rheumatoid arthritis even when treatments achieve ... Rheumatoid Arthritis on the Rise in WomenFood Consumer Pain Remains a Significant Issue for Women With RA in Modern Treatment EraMedscape Rheumatoid Arthritis Afflicts Nearly Seventy Five Percent Of Women DailyExaminer.com PharmiWeb.com (press release) -Oneindia all 83 news articles »

Pfizer Cuts Off Arthritis Drug - Forbes

Pfizer Cuts Off Arthritis Drug Forbes Trubion Pharmaceuticals said late Monday that Pfizer had decided to discontinue development of one of the two investigational rheumatoid arthritis drugs on ... Trubion says Pfizer to stop arthritis drug developmentReuters Pfizer Focuses, Investors Should CheerMotley Fool Pfizer Opts for Earlier-Stage CD20 Program from TrubionBioWorld Online MarketWatch all 48 news articles »

Pfizer's Celebrex Causes Less Stomach Upset, Bleeding - BusinessWeek

MSN Health & Fitness

Pfizer's Celebrex Causes Less Stomach Upset, Bleeding BusinessWeek The scientists tracked 4484 patients with osteoarthritis or rheumatoid arthritis who were at risk for developing ulcers or other gastrointestinal problems. ... New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published by The Lancet ...PR Newswire (press release) Celecoxib May Be Better for GI TractMedPage Today all 34 news articles »

Cipla Targets Billion-a-Year Roche, Amgen Drugs - BusinessWeek

Stock Watch

Cipla Targets Billion-a-Year Roche, Amgen Drugs BusinessWeek Cipla is targeting 8 to 10 treatments for rheumatoid arthritis, colorectal cancer, allergic asthma, and head and neck cancer that aren't covered by patents ... Second innings in biotechBusiness Standard all 47 news articles »